RxDoctor Payments Data

Yuna Farah-Peterson, DPM

Podiatrist · Point Pleasant, WVNPI 1972123149

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,758 of the $2,923 with a category attached, or 60.2%. 15 manufacturers reported payments, led by Arthrex at 33.6% of the total. Reporting peaked in 2023 at $1,931 and has fallen 69.2% since, to $594 in 2025.

$2,923in general payments, 2019–2025

Across 72 payments — averaging $40.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$982
  • Paragon 28, Inc.$535
  • Paratek Pharmaceuticals, Inc.$414
  • Treace Medical Concepts, Inc.$227
  • Organogenesis Inc.$211
  • Tactile Systems Technology Inc$172
  • plus $382 from 9 others

What the payments were for

  • Travel & lodging$1,16540%
  • Food & beverage$1,75860%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,923 in reported general payments places this provider in the 75th percentile of 37 podiatrist providers in West Virginia.

See all podiatrist providers in West Virginia

Medicare billing

Part B allowed, 2024
$78,517
Medicare patients
203
Services billed
984

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole29$744
Terbinafine Hcl36$609
Ammonium Lactate18$503
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip17$334
Ciprofloxacin Hcl32$318
Methylprednisolone57$308
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav34$290
Doxycycline Hyclate18$186
Triamcinolone Acetonide12$96
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim16$80
Colchicine14$79
Ibuprofen11$38

Paid to pharmacies, not to this prescriber.

Other podiatrist in Point Pleasant

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →